Pulmonary arterial hypertension (PAH) is a devastating disease characterized by arteriopathy in the small to medium-sized distal pulmonary arteries, often accompanied by infiltration of inflammatory ...

Hypertension is one of the most prevalent non-transmittable diseases in the world, with 29% of the world's population expected to suffer from the condition by 2025. Despite substantial advances in ...

Hypertension is a major modifiable risk factor for renal, cerebrovascular, and cardiovascular disease. The pathophysiology of hypertension, also known as high blood pressure, is complex, whereby both ...

Investigators provide recent information on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, focusing specifically on its impact on women. Pulmonary ...

Expert Rev Cardiovasc Ther. 2012;10(11):1367-1373. The elderly merit special consideration for BP measurement. These hypertensive patients are prone to have autonomic failure with postural hypotension ...

Acquired SEPS are associated with portal hypertension, cirrhosis, and complications of decompensation. In particular, the effects of NVEPS on portal pressure are variable, but there is evidence of ...

Although some cases of PAH have known causes, such as genetic factors, many cases have no identifiable underlying cause and are designated as idiopathic. Early diagnosis and treatment are critical for ...

The World Health Organization estimates that there are at least 270 million people living with hypertension in China — a fraction of whom are being adequately treated, if at all. Part of the problem ...

Patients with MPNs are at increased risk for nonthrombotic conditions, including heart failure and pulmonary hypertension, necessitating improved understanding and management strategies. Pulmonary ...